资源描述：
《罗哌卡因复合布托啡诺用于臂丛神经阻滞临床观察.doc》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、罗哌卡因复合布托啡诺用于臂丛神经阻滞临床观察【摘要】目的：观察罗哌卡因复合少量布托啡诺用于臂丛神经阻滞的麻醉效果和安全性。方法：选择笔者所在医院收治的行上肢手术的80例患者，均为ASAI-II级。采用随机数字表法将其分为A、B两组，各40例。A组给予0.5%罗哌卡因20ml+布托啡诺1mg,B组给予0.5%罗哌卡因20ml,行臂丛阻滞，记录阻滞前、阻滞后10min、阻滞后30min、阻滞后60min时收缩压（SBP）、舒张压（DBP）、心率（IIR）的变化，并进行麻醉满意度评分及不良反应记录。结果：两组各时间点的SBP、DBP、HR比较差
2、异无统计学意义（P>0.05）,A组麻醉满意度明显优于B组，A组镇痛持续时间明显长于B组，差异均有统计学意义（P3.05）。结论：罗哌卡因复合少量布托啡诺可取得以好的麻醉效果，且能延长麻醉镇痛持续时间。【关键词】罗哌卡因；布托啡诺；臂丛阻滞中图分类号R614文献标识码A文章编号1674-6805(2014)13-0017-02ClinicalObservationofRopivcaineCombinedwithButorphanolonBrachialPlexusBlock/PANWei-tang,CHENGBi~na,LTURong-f
3、ang,etal.//ChineseandForeignMedicalResearch,2014,12(13)：17-18[Abstract1Objective：ToobservetheclinicaleffectsofRopivcainecombinedwithButorphanolonbrachialplexusblock.Method：Selectingtheauthorshospitaladmissionlineofupperextremitysurgeryof80patients,wereASAI-IIlevel.Byusing
4、themethodtorandomnumbertableweredividedintoA,Bgroups,40casesineach.Agroupwasgiven0.5%Ropivcaine20ml+Butorphanol1mg,Bgroupwasgiven0.5%Ropivcaine20ml,lineofbrachialplexusblock,brachialplexusblock,10minafterrecordbeforetheblock,blockafter60min,blockafter30min,blockthesystoli
5、cbloodpressure(SBP),diastolicbloodpressure(DBP),thechangeofheartrate(HR),andanesthesiasatisfactionscoreandrecordadversereactions.Infrontoftheblock,blockafter10,30,60minutes,recordingsystolicbloodpressure(SBP),diastolicbloodpressure(DBP),thechangeofheartrate(HR),andanesthe
6、siasatisfactionscoreandrecordadversereactions.Result：TwogroupsofeachpointtimeofSBP,DBP,HRcomparisondifferencehasnostatisticalsignificance(P>0.05).ThesatisfactionofanesthesiainAgroupwasbetterthanthatinBgroup.ThedurationofanesthesiainAgroupwassignificantlylongerthanthatinBg
7、roup,thedifferencewasstatisticallysignificant(P<0.05).Conclusion：TheanalgesiaeffectofRopivcainecombinedwithButorphanolonbrachialplexusblockisgood,canprolongtheanesthesiatime.[Keywords]Ropivcaine；Butorphanol；BrachialplexusblockFirst-authorJsaddress：TheSecondPeople'sHospita
8、lofYiduCity,Yidu443300,China局麻药加入阿片类药物用于外周神经阻滞，可以提高麻醉效果，减少不良反应发生，己成为临床常用麻醉技术。布托啡诺是一种混合型阿片受体激动和拮抗
